Team van professor Jacques De Grève |
|
|
|
Projecttitle: Prospective evaluation of small molecule EGFR-1 tyrosine kinase inhibition as a first-line treatment in a phase II study in patients with advanced non-small cell lung cancer (NSCLC) harbouring a mutant EGFR-gene
Vrije Universiteit Brussel
Toegekende bedrag: 110 000 € verdeeld over 3 jaar |












